Support

Country Websites

PureFlow™ Lactate Solution

NxStage Premixed Dialysate Fluids make dialysis accessible.

NxStage systems can use premixed dialysate bagged solutions that are manufactured to United States Pharmacopeia (USP) and/or European Pharmacopoeia (EP) specifications. Premixed dialysate bags are terminally sterilized and non-pyrogenic (<0.25 EU/mL). Premixed fluid bags also meet ISO 10993 Biological Evaluation of Medical Devices, which consists of a series of tests intended to address potential biological risks arising from the use of a medical device. 

 

Benefits

Flexibility to Travel

Premixed, 5-liter dialysate bags are portable along with the System One™ Cycler. This may offer patients the freedom to travel, with a physician prescription, without interrupting their treatment schedule.

Simplify Treatments

Usage by the patient has been simplified. The physician determines the number of bags the patient requires; the patient simply hangs and connects the bags for treatment.

 

Formulations

NxStage Premixed Dialysate Bags are available in the following formulations for home hemodialysis.


Product disclaimer: Not all products are cleared or available for sale in all countries

For more information on the PureFlow Lactate Solution, call NxStage at 1-866-NXSTAGE (697-8243) or fill out the form to speak with an expert.

Related Pages

PUREFLOW SL WATER AND DIALYSATE PREPARATION SYSTEM

NxStage PureFlow SL offers water purification and dialysate production in one integrated unit specifically designed for use at home or in-center.

NXSTAGE VERSI®HD WITH GUIDEME SOFTWARE

Ease of use extends to the steps to begin a treatment: Insert a single-use cartridge into the cycler, spike a bag of saline, and press the start priming button on the touch screen. Pressing the ‘Guide Me’ button displays step-by-step illustrated instructions to assist in a particular task.

Risks and Responsibilities

Patients should review the following information carefully and discuss it with their doctors to decide whether home hemodialysis with NxStage systems is right for them.

 

Users should weigh the risks and benefits of performing home hemodialysis with NxStage systems. 

  • Medical staff will not be present to respond to health emergencies that might happen during home treatments. 
  • Users and their care partners will be responsible for all aspects of their hemodialysis treatments from start to finish. 
  • Users may not experience the reported benefits of home, more frequent or nocturnal hemodialysis with the NxStage systems. 
  • The NxStage systems require a prescription for use.  

Certain forms of home hemodialysis have additional risks.

  • If a doctor prescribes more frequent home hemodialysis, vascular access is exposed to more frequent use which may lead to access related complications, including infection of the site.  Doctors should evaluate the medical necessity of more frequent treatments and discuss the risks and benefits of more frequent therapy with users. 
  • If a doctor prescribes “solo/independent” home hemodialysis without a care partner during waking hours, risks of significant injury or death increase because no one is present to help users respond to health emergencies.  If users experience needles coming out, blood loss, or very low blood pressure during solo home hemodialysis, they may lose consciousness or become physically unable to correct the health emergency.  Users will need additional ancillary devices and training to perform solo home hemodialysis. 
  • If a doctor prescribes “nocturnal” home hemodialysis at night while the user and a care partner are sleeping, risks increase due to the length of treatment time and because therapy is performed while users and their care partners are sleeping. These risks include, among other things, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow or increased treatment time or both, and delayed response to alarms when waking from sleep.  

 

APM2468 Rev. E

Contact

Country Websites

All Contact Information

Social Media

© 2006-2024 Fresenius Medical Care. All Rights Reserved.

Privacy Statement

Terms of Use